<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-052346</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Topical cyclosporine in the treatment of ocular actinic prurigo</dc:title>
<dc:description xml:lang="en">Case report: A 14-year-old girl from Peru suffered        severe limbitis and conjunctivitis. She also presented        with clinical skin features diagnosed as actinic        prurigo (AP). Her symptoms were successfully        controlled with sustained topical therapy of 2%        Cyclosporine A.        Discussion: AP is an idiopathic photodermatosis        that affects mainly the hispanic population of Latin        America. There are ocular signs of severe limbitis        and conjunctivitis (like atopic keratoconjunctivitis)        in 45% of cases. Literature on the subject is very        limited and currently topical cyclosporine seems to        be the best therapy available</dc:description>
<dc:creator>Peláez-Restrepo, N</dc:creator>
<dc:creator>Pastor-Nieto, B</dc:creator>
<dc:creator>Ortiz-Castillo, J. V</dc:creator>
<dc:creator>De-Lucas-Laguna, R</dc:creator>
<dc:creator>Fonseca-Sandomingo, A</dc:creator>
<dc:creator>Boto-de-los-Bueis, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Caso clínico: Presentamos el caso de una mujer de        14 años latinoamericana, con una limbo-conjuntivitis        severa. Habia sido diagnosticada de prúrigo actínico        (PA) por el dermatólogo. Con el diagnóstico de        PA ocular se inició tratamiento con colirio de        ciclosporina A 2% con buena respuesta.        Discusión: El PA es una fotodermatosis idiopática        que afecta principalmente a la población mestiza de        Latino América. Los ojos se ven afectados en el        45% de los casos, como una limbo-conjuntivitis        severa semejante a la atópica. A pesar de la escasa        bibliografía existente, la ciclosporina tópica representa        la mejor alternativa en el tratamiento del PA        ocular</dc:description>
<dc:source>Arch Soc Esp Oftalmol;81(11): 661-664, nov. 2006. ilus</dc:source>
<dc:identifier>ibc-052346</dc:identifier>
<dc:title xml:lang="es">Ciclosporina tópica como tratamiento del prúrigo actínico ocular</dc:title>
<dc:subject>^d287</dc:subject>
<dc:subject>^d11974^s22057</dc:subject>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d30164^s22073</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d11217^s22057</dc:subject>
<dc:type>article</dc:type>
<dc:date>200611</dc:date>
</metadata>
</record>
</ibecs-document>
